Growth Metrics

Eledon Pharmaceuticals (ELDN) Cash from Financing Activities (2013 - 2025)

Eledon Pharmaceuticals posted quarterly Cash from Financing Activities of $53.7 million for Q4 2025, down 33.02% year-on-year from $80.2 million in Q4 2024, and up 46588.7% on a QoQ basis from $115000.0 in Q1 2025.

Eledon Pharmaceuticals (ELDN) has 11 years of Cash from Financing Activities data on file, last reported at $53.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 33.02% year-over-year to $53.7 million; the trailing twelve-month figure through Dec 2025 stood at $53.8 million (down 59.7% YoY), and the FY2025 full-year result was $53.8 million, down 59.7% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at $53.7 million, up from $115000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $80.2 million in Q4 2024 and bottomed at -$450000.0 in Q1 2021.
  • The 3-year median for Cash from Financing Activities is $2.7 million (2024), against an average of $23.4 million.
  • The widest annual swing landed in 2021, when Cash from Financing Activities sank 108.67%; it then soared 11400.0% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at $1000.0 in 2021, then surged by 8016600.0% to $80.2 million in 2024, then slumped by 33.02% to $53.7 million in 2025.
  • The last three Cash from Financing Activities figures came in at $53.7 million (Q4 2025), $115000.0 (Q1 2025), and $80.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 7.00 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -600,000.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 53,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -538.80 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -802.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.71 Mn
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 53.69 Mn
Dec 31, 2025 53.69 Mn
Mar 31, 2025 115,000.00
Mar 31, 2025 115,000.00
Dec 31, 2024 80.17 Mn
Dec 31, 2024 80.17 Mn
Sep 30, 2024 5.28 Mn
Sep 30, 2024 5.28 Mn
Jun 30, 2024 48.07 Mn
Jun 30, 2024 48.07 Mn
Mar 31, 2024 1,000.00
Mar 31, 2024 1,000.00
Sep 30, 2021 1,000.00
Sep 30, 2021 1,000.00
Mar 31, 2021 -450,000.00
Mar 31, 2021 -450,000.00
Dec 31, 2020 9.16 Mn
Dec 31, 2020 9.16 Mn
Sep 30, 2020 95.23 Mn
Sep 30, 2020 95.23 Mn
Mar 31, 2020 5.19 Mn
Mar 31, 2020 5.19 Mn
Jun 30, 2019 9.57 Mn
Jun 30, 2019 9.57 Mn
Mar 31, 2019 107,000.00
Mar 31, 2019 107,000.00
Dec 31, 2018 1,000.00
Dec 31, 2018 1,000.00
Sep 30, 2018 70,000.00
Sep 30, 2018 70,000.00
Mar 31, 2018 7.49 Mn
Mar 31, 2018 7.49 Mn
Dec 31, 2017 750,000.00
Dec 31, 2017 750,000.00
Jun 30, 2017 6.72 Mn
Jun 30, 2017 6.72 Mn
Mar 31, 2017 400,000.00
Mar 31, 2017 400,000.00
Sep 30, 2016 2.89 Mn
Sep 30, 2016 2.89 Mn
Mar 31, 2016 37,000.00
Mar 31, 2016 37,000.00
Dec 31, 2015 48,000.00
Dec 31, 2015 48,000.00
Sep 30, 2015 188,000.00
Sep 30, 2015 188,000.00
Jun 30, 2015 222,000.00
Jun 30, 2015 222,000.00
Mar 31, 2015 55,000.00
Mar 31, 2015 55,000.00
Dec 31, 2014 6.25 Mn
Dec 31, 2014 6.25 Mn
Sep 30, 2014 88.94 Mn
Sep 30, 2014 88.94 Mn
Jun 30, 2014 -437,000.00
Jun 30, 2014 -437,000.00
Mar 31, 2014 49,000.00
Mar 31, 2014 49,000.00
Dec 31, 2013 15.47 Mn
Dec 31, 2013 15.47 Mn